免疫性血小板减少症的管理：2017年韩国专家建议
Management of immune thrombocytopenia: Korean experts recommendation in 2017.
作者信息
Jang Jun Ho, Kim Ji Yoon, Mun Yeung-Chul, Bang Soo-Mee, Lim Yeon Jung, Shin Dong-Yeop, Choi Young Bae, Yhim Ho-Young, Lee Jong Wook, Kook Hoon
机构信息
Department of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea.
出版信息
Blood Res. 2017 Dec;52(4):254-263. doi: 10.5045/br.2017.52.4.254. Epub 2017 Dec 26.
Abstract
Management options for patients with immune thrombocytopenia (ITP) have evolved substantially over the past decades. The American Society of Hematology published a treatment guideline for clinicians referring to the management of ITP in 2011. This evidence-based practice guideline for ITP enables the appropriate treatment of a larger proportion of patients and the maintenance of normal platelet counts. Korean authority operates a unified mandatory national health insurance system. Even though we have a uniform standard guideline enforced by insurance reimbursement, there are several unsolved issues in real practice in ITP treatment. To optimize the management of Korean ITP patients, the Korean Society of Hematology Aplastic Anemia Working Party (KSHAAWP) reviewed the consensus and the Korean data on the clinical practices of ITP therapy. Here, we report a Korean expert recommendation guide for the management of ITP.
摘要
在过去几十年里，免疫性血小板减少症（ITP）患者的管理方案有了显著发展。美国血液学会于2011年发布了一份针对临床医生的ITP管理治疗指南。这份基于证据的ITP实践指南能够使更大比例的患者得到恰当治疗并维持正常血小板计数。韩国官方运营着一个统一的强制性国家医疗保险系统。尽管我们有由保险报销强制实施的统一标准指南，但在ITP治疗的实际操作中仍存在一些未解决的问题。为了优化韩国ITP患者的管理，韩国血液学会再生障碍性贫血工作组（KSHAAWP）回顾了ITP治疗临床实践的共识和韩国数据。在此，我们报告一份韩国ITP管理专家推荐指南。
相似文献
1
Management of immune thrombocytopenia: Korean experts recommendation in 2017.免疫性血小板减少症的管理：2017年韩国专家建议
Blood Res. 2017 Dec;52(4):254-263. doi: 10.5045/br.2017.52.4.254. Epub 2017 Dec 26.
2
Management of immune thrombocytopenia: 2022 update of Korean experts recommendations.免疫性血小板减少症的管理：2022年韩国专家建议更新版
Blood Res. 2022 Mar 31;57(1):20-28. doi: 10.5045/br.2022.2022043.
3
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.美国血液学会 2011 年免疫性血小板减少症循证实践指南。
Blood. 2011 Apr 21;117(16):4190-207. doi: 10.1182/blood-2010-08-302984. Epub 2011 Feb 16.
4
Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. The American Society of Hematology ITP Practice Guideline Panel.特发性血小板减少性紫癜的诊断与治疗：美国血液学会的建议。美国血液学会特发性血小板减少性紫癜实践指南小组。
Ann Intern Med. 1997 Feb 15;126(4):319-26. doi: 10.7326/0003-4819-126-4-199702150-00010.
5
[Etiology and clinical characteristics of pregnancy-emerged thrombocytopenia].[妊娠合并血小板减少症的病因及临床特征]
Zhonghua Fu Chan Ke Za Zhi. 2011 Nov;46(11):834-9.
6
Chinese guidelines for treatment of adult primary immune thrombocytopenia.成人原发性免疫性血小板减少症中国治疗指南。
Int J Hematol. 2018 Jun;107(6):615-623. doi: 10.1007/s12185-018-2445-z. Epub 2018 Apr 4.
7
Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists.成人免疫性血小板减少症（ITP）抗栓治疗管理：ITP 专家和血液科肿瘤学家的调查。
J Thromb Thrombolysis. 2018 Jul;46(1):24-30. doi: 10.1007/s11239-018-1649-7.
8
A characteristic flow cytometric pattern with broad forward scatter and narrowed side scatter helps diagnose immune thrombocytopenia (ITP).具有宽前向散射和窄侧向散射特征的流式细胞术模式有助于诊断免疫性血小板减少症 (ITP)。
Int J Hematol. 2018 Aug;108(2):151-160. doi: 10.1007/s12185-018-2454-y. Epub 2018 Apr 16.
9
Immune thrombocytopenia nomenclature, consensus reports, and guidelines: what are the consequences for daily practice and clinical research?免疫性血小板减少症命名、共识报告和指南：对日常实践和临床研究有何影响？
Semin Hematol. 2013 Jan;50 Suppl 1:S50-4. doi: 10.1053/j.seminhematol.2013.03.008.
10
Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group.临床实践中成人原发性免疫性血小板减少症（ITP）的管理：西班牙ITP专家组的共识方法
Adv Hematol. 2019 Aug 22;2019:4621416. doi: 10.1155/2019/4621416. eCollection 2019.
引用本文的文献
1
Immune Thrombocytopenia Induced by Helicobacter pylori Infection: A Case Report and Literature Review.幽门螺杆菌感染诱发的免疫性血小板减少症：一例报告及文献综述
Cureus. 2025 Apr 13;17(4):e82167. doi: 10.7759/cureus.82167. eCollection 2025 Apr.
2
Refractory immune thrombocytopenia treated with low-dose decitabine combined with recombinant human thrombopoietin or eltrombopag: Two case reports.低剂量地西他滨联合重组人血小板生成素或艾曲泊帕治疗难治性免疫性血小板减少症：两例病例报告
Medicine (Baltimore). 2025 Feb 7;104(6):e41449. doi: 10.1097/MD.0000000000041449.
3
Comparison of hematologic parameters, serum electrolytes, and lipid profiles among dyspeptic patients with and without Helicobacter pylori infection attending Jimma Medical Center, Jimma, South West Ethiopia.比较在埃塞俄比亚西南吉姆马医疗中心就诊的伴有和不伴有幽门螺杆菌感染的消化不良患者的血液学参数、血清电解质和血脂谱。
PLoS One. 2024 Nov 4;19(11):e0310047. doi: 10.1371/journal.pone.0310047. eCollection 2024.
4
The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity.免疫调节剂和血小板生成素受体激动剂在合并出血的埃及原发性免疫性血小板减少症患者中的疗效及药物不良反应模式
Pharmaceuticals (Basel). 2023 Jun 12;16(6):868. doi: 10.3390/ph16060868.
5
Eradication therapy may decrease the risk of immune thrombocytopenia after Helicobacter pylori infection: a retrospective cohort study in Taiwan.根除疗法可能降低台湾幽门螺杆菌感染后免疫性血小板减少症的风险：一项回顾性队列研究。
BMC Gastroenterol. 2023 Feb 8;23(1):36. doi: 10.1186/s12876-023-02664-z.
6
A rare case of pediatric immune thrombocytopenia with secondary antiphospholipid syndrome in Korea.韩国一例罕见的小儿免疫性血小板减少症合并继发性抗磷脂综合征。
Blood Res. 2022 Sep 30;57(3):241-243. doi: 10.5045/br.2022.2022074. Epub 2022 Aug 3.
7
Management of immune thrombocytopenia: 2022 update of Korean experts recommendations.免疫性血小板减少症的管理：2022年韩国专家建议更新版
Blood Res. 2022 Mar 31;57(1):20-28. doi: 10.5045/br.2022.2022043.
8
induced Immune Thrombocytopenic Purpura and perspective role of eradication therapy for treating Immune Thrombocytopenic Purpura.免疫性血小板减少性紫癜与根除疗法在治疗免疫性血小板减少性紫癜中的潜在作用
AIMS Microbiol. 2021 Sep 2;7(3):284-303. doi: 10.3934/microbiol.2021018. eCollection 2021.
9
Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).新型 10%静脉注射免疫球蛋白产品治疗原发免疫性血小板减少症（ITP）患者的疗效和安全性。
J Korean Med Sci. 2018 Apr 24;33(19):e142. doi: 10.3346/jkms.2018.33.e142. eCollection 2018 May 7.
本文引用的文献
1
Clinical updates in adult immune thrombocytopenia.成人免疫性血小板减少症的临床进展
Blood. 2017 May 25;129(21):2829-2835. doi: 10.1182/blood-2017-03-754119. Epub 2017 Apr 17.
2
Using a standardised protocol was effective in reducing hospitalisation and treatment use in children with newly diagnosed immune thrombocytopenia.使用标准化方案可有效减少新诊断为免疫性血小板减少症儿童的住院和治疗使用。
Acta Paediatr. 2017 Oct;106(10):1617-1623. doi: 10.1111/apa.13859. Epub 2017 May 11.
3
Long-term complications of splenectomy in adult immune thrombocytopenia.成人免疫性血小板减少症脾切除术后的长期并发症
Medicine (Baltimore). 2016 Nov;95(48):e5098. doi: 10.1097/MD.0000000000005098.
4
Long-term results of splenectomy in adult chronic immune thrombocytopenia.成人慢性免疫性血小板减少症脾切除的长期结果
Eur J Haematol. 2017 Mar;98(3):235-241. doi: 10.1111/ejh.12821. Epub 2016 Nov 7.
5
Clinical course and prognostic factors of childhood immune thrombocytopenia: single center experience of 10 years.儿童免疫性血小板减少症的临床病程及预后因素：10年单中心经验
Korean J Pediatr. 2016 Aug;59(8):335-40. doi: 10.3345/kjp.2016.59.8.335. Epub 2016 Aug 24.
6
Platelet count recovery after intravenous immunoglobulin predicts a favorable outcome in children with immune thrombocytopenia.静脉注射免疫球蛋白后血小板计数的恢复预示着免疫性血小板减少症患儿的良好预后。
Blood Res. 2016 Jun;51(2):95-101. doi: 10.5045/br.2016.51.2.95. Epub 2016 Jun 23.
7
Controversies in the treatment of immune thrombocytopenia.免疫性血小板减少症治疗中的争议
Curr Opin Hematol. 2016 Sep;23(5):479-85. doi: 10.1097/MOH.0000000000000270.
8
Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children : Splenectomy in ITP.成人和儿童慢性持续性免疫性血小板减少症（ITP）脾切除术后的长期结局：ITP的脾切除术
Ann Hematol. 2016 Sep;95(9):1429-34. doi: 10.1007/s00277-016-2738-3. Epub 2016 Jul 2.
9
Viruses, anti-viral therapy, and viral vaccines in children with immune thrombocytopenia.免疫性血小板减少症患儿中的病毒、抗病毒治疗及病毒疫苗
Semin Hematol. 2016 Apr;53 Suppl 1:S70-2. doi: 10.1053/j.seminhematol.2016.04.021. Epub 2016 Apr 7.
10
Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.罗米司亭治疗儿童免疫性血小板减少症：一项 3 期、随机、双盲、安慰剂对照研究。
Lancet. 2016 Jul 2;388(10039):45-54. doi: 10.1016/S0140-6736(16)00279-8. Epub 2016 Apr 18.
Zotero 插件